EligibleTrials

Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)

Recruiting · NCT06914544 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Schleswig-Holstein

View the official record on ClinicalTrials.gov →
Prostate Cancer

Interventions studied

Hypofractionated Radiosurgery

What this trial is about

Hypofractionated radiosurgery with 5 fractions is considered standard of care for localized prostate cancer. The investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 3 fractions in patients with localised prostate cancer under the hypothesis that the ratio of patients with late GU and GI toxicity ≥ grade 2 after 1 year amounts to 8.4% and 1.3% and is significant lower than 16.4% and 5.7% currently.

Who can take part

Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

6 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.